Cingulate Inc. Common Stock (CING) is a publicly traded Healthcare sector company. As of July 23, 2026, CING trades at $4.86 with a market cap of $65.19M and a P/E ratio of -1.13. CING moved +0.41% today. Year to date, CING is +11.52%; over the trailing twelve months it is -13.11%. Its 52-week range spans $3.16 to $11.89. Analyst consensus is strong buy with an average price target of $22.50. Rallies surfaces CING's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CING insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $4.86 |
| Market Cap | $65.19M |
| P/E Ratio | -1.13 |
| EPS | $-4.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.89 |
| 52-Week Low | $3.16 |
| Volume | 101.92K |
| Avg Volume | 0 |
| Revenue (TTM) | $-1.79M |
| Net Income | $-27.91M |
| Gross Margin | 0.00% |
4 analysts cover CING: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.50.